Scolaris Content Display Scolaris Content Display

Profilaxis con levosimendán para la prevención del síndrome de gasto cardíaco bajo y la mortalidad en pacientes pediátricos sometidos a cirugía por una cardiopatía congénita

Appendices

Appendix 1. Search strategies

CENTRAL

#1 MeSH descriptor: [Heart Defects, Congenital] explode all trees
#2 MeSH descriptor: [Heart Diseases] explode all trees and with qualifier(s): [Congenital ‐ CN]
#3 (heart near/2 (defect* or abnormal* or malform*))
#4 (congenital near/2 (heart or cardiac or cardio*))
#5 deletion next syndrome*
#6 (alagille* near/2 syndrome*)
#7 (watson* near/2 syndrome*)
#8 (hepatofacioneurocardiovertebral near/2 syndrome*)
#9 cardiovertebral near/2 syndrome*
#10 (arteriohepatic near/2 dysplasia*)
#11 "hepatic ductular hypoplasia*"
#12 aort* near/3 coarctation*
#13 (arrhythmogenic near/3 ventricular)
#14 Barth next Syndrome
#15 ((heart* or cor) 2 triatria*)
#16 (subdivided near/3 atrium*)
#17 "coronary vessel anomal*"
#18 myocardial next bridging*
#19 "criss‐cross heart*"
#20 "crisscross heart*"
#21 "criss cross heart*"
#22 dextrocardia*
#23 (kartagener* near/2 (syndrome* or triad))
#24 siewert next syndrome*
#25 "polynesian bronchiectas?s"
#26 "primary ciliary dyskinesia"
#27 (paten* near/2 ductus near/2 arteriosus)
#28 (ebstein* near/2 (anomal* or malform*))
#29 ectopia next cordis
#30 (Eisenmenger* near/2 (complex or syndrome))
#31 ((heart or cardiac) near/2 "septal defect*")
#32 heterotaxy next syndrome*
#33 polysplenia next syndrome*
#34 asplenia next syndrome*
#35 ambiguus near/3 situs
#36 isomerism
#37 ivemark next syndrome
#38 visceral next heterotax*
#39 "hypoplastic left heart syndrome"
#40 isolated next noncompaction
#41 isolated next non‐compaction
#42 leopard next syndrome*
#43 cardiomyopathic* next lentiginosis
#44 lentigines next syndrome*
#45 levocardia
#46 marfan* next syndrome
#47 noonan next syndrome
#48 turner* next syndrome
#49 fallot* near/2 tetralogy
#50 (transpos* near/4 (arter* or vessel*))
#51 (tricuspid near/2 atresias)
#52 (fallot* near/2 trilogy)
#53 turner* next syndrome
#54 bonnevie‐ullrich next syndrome
#55 "bonnevie ullrich syndrome"
#56 "bonnevie‐ullrich status"
#57 "bonnevie ullrich status"
#58 "ullrich‐turner syndrome"
#59 (gonadal near/2 dysgenesis)
#60 "univentricular heart"
#61 "arterial switch"
#62 norwood*
#63 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or #35 or #36 or #37 or #38 or #39 or #40 or #41 or #42 or #43 or #44 or #45 or #46 or #47 or #48 or #49 or #50 or #51 or #52 or #53 or #54 or #55 or #56 or #57 or #58 or #59 or #60 or #61 or #62
#64 levosimendan or levosimedan or or1259 or "or 1259" or simdax
#65 MeSH descriptor: [Cardiotonic Agents] this term only
#66 (inotropic near/2 (agent* or drug* or medicat* or act*))
#67 inodilator*
#68 (calcium near/2 sensiti*)
#69 #64 or #65 or #66 or #67 or #68
#70 #63 and #69

MEDLINE

1. exp Heart Defects, Congenital/
2. exp Heart Diseases/cn [Congenital]
3. (heart adj2 (defect* or abnormal* or malform*)).tw.
4. (congenital adj2 (heart or cardiac or cardio*)).tw.
5. deletion syndrome*.tw.
6. (alagille* adj2 syndrome*).tw.
7. (watson* adj2 syndrome*).tw.
8. (hepatofacioneurocardiovertebral adj2 syndrome*).tw.
9. (cardiovertebral adj2 syndrome*).tw.
10. (arteriohepatic adj2 dysplasia*).tw.
11. hepatic ductular hypoplasia*.tw.
12. (aort* adj3 coarctation*).tw.
13. (arrhythmogenic adj3 ventricular).tw.
14. Barth Syndrome.tw.
15. ((heart* or cor) adj2 triatria*).tw.
16. (subdivided adj3 atrium*).tw.
17. coronary vessel anomal*.tw.
18. myocardial bridging*.tw.
19. criss‐cross heart*.tw.
20. crisscross heart*.tw.
21. criss cross heart*.tw.
22. dextrocardia*.tw.
23. (kartagener* adj2 (syndrome* or triad)).tw.
24. siewert syndrome*.tw.
25. polynesian bronchiectas?s.tw.
26. primary ciliary dyskinesia.tw.
27. (paten* adj2 ductus adj2 arteriosus).tw.
28. (ebstein* adj2 (anomal* or malform*)).tw.
29. ectopia cordis.tw.
30. (Eisenmenger* adj2 (complex or syndrome)).tw.
31. ((heart or cardiac) adj2 septal defect*).tw.
32. heterotaxy syndrome*.tw.
33. polysplenia syndrome*.tw.
34. asplenia syndrome*.tw.
35. (ambiguus adj3 situs).tw.
36. isomerism.tw.
37. ivemark syndrome.tw.
38. visceral heterotax*.tw.
39. hypoplastic left heart syndrome.tw.
40. isolated noncompaction.tw.
41. isolated non‐compaction.tw.
42. leopard syndrome*.tw.
43. cardiomyopathic* lentiginosis.tw.
44. lentigines syndrome*.tw.
45. levocardia.tw.
46. marfan* syndrome.tw.
47. noonan syndrome.tw.
48. turner* syndrome.tw.
49. (fallot* adj2 tetralogy).tw.
50. (transpos* adj4 (arter* or vessel*)).tw.
51. (tricuspid adj2 atresias).tw.
52. (fallot* adj2 trilogy).tw.
53. turner* syndrome.tw.
54. bonnevie‐ullrich syndrome.tw.
55. bonnevie ullrich syndrome.tw.
56. bonnevie‐ullrich status.tw.
57. bonnevie ullrich status.tw.
58. ullrich‐turner syndrome.tw.
59. (gonadal adj2 dysgenesis).tw.
60. univentricular heart.tw.
61. arterial switch.tw.
62. norwood*.tw.
63. or/1‐62
64. levosimendan.tw.
65. levosimedan.tw.
66. or1259.tw.
67. "or 1259".tw.
68. simdax.tw.
69. Cardiotonic Agents/
70. (inotropic adj2 (agent* or drug* or medicat* or act*)).tw.
71. inodilator*.tw.
72. (calcium adj2 sensiti*).tw.
73. or/64‐72
74. 63 and 73
75. randomized controlled trial.pt.
76. controlled clinical trial.pt.
77. randomized.ab.
78. placebo.ab.
79. drug therapy.fs.
80. randomly.ab.
81. trial.ab.
82. groups.ab.
83. 75 or 76 or 77 or 78 or 79 or 80 or 81 or 82
84. exp animals/ not humans.sh.
85. 83 not 84
86. 74 and 85

Embase

1. exp congenital heart malformation/
2. exp heart disease/cn [Congenital Disorder]
3. (heart adj2 (defect* or abnormal* or malform*)).tw.
4. (congenital adj2 (heart or cardiac or cardio*)).tw.
5. deletion syndrome*.tw.
6. (alagille* adj2 syndrome*).tw.
7. (watson* adj2 syndrome*).tw.
8. (hepatofacioneurocardiovertebral adj2 syndrome*).tw.
9. (cardiovertebral adj2 syndrome*).tw.
10. (arteriohepatic adj2 dysplasia*).tw.
11. hepatic ductular hypoplasia*.tw.
12. (aort* adj3 coarctation*).tw.
13. (arrhythmogenic adj3 ventricular).tw.
14. Barth Syndrome.tw.
15. ((heart* or cor) adj2 triatria*).tw.
16. (subdivided adj3 atrium*).tw.
17. coronary vessel anomal*.tw.
18. myocardial bridging*.tw.
19. criss‐cross heart*.tw.
20. crisscross heart*.tw.
21. criss cross heart*.tw.
22. dextrocardia*.tw.
23. (kartagener* adj2 (syndrome* or triad)).tw.
24. siewert syndrome*.tw.
25. polynesian bronchiectas?s.tw.
26. primary ciliary dyskinesia.tw.
27. (paten* adj2 ductus adj2 arteriosus).tw.
28. (ebstein* adj2 (anomal* or malform*)).tw.
29. ectopia cordis.tw.
30. (Eisenmenger* adj2 (complex or syndrome)).tw.
31. ((heart or cardiac) adj2 septal defect*).tw.
32. heterotaxy syndrome*.tw.
33. polysplenia syndrome*.tw.
34. asplenia syndrome*.tw.
35. (ambiguus adj3 situs).tw.
36. isomerism.tw.
37. ivemark syndrome.tw.
38. visceral heterotax*.tw.
39. hypoplastic left heart syndrome.tw.
40. isolated noncompaction.tw.
41. isolated non‐compaction.tw.
42. leopard syndrome*.tw.
43. cardiomyopathic* lentiginosis.tw.
44. lentigines syndrome*.tw.
45. levocardia.tw.
46. marfan* syndrome.tw.
47. noonan syndrome.tw.
48. turner* syndrome.tw.
49. (fallot* adj2 tetralogy).tw.
50. (transpos* adj4 (arter* or vessel*)).tw.
51. (tricuspid adj2 atresias).tw.
52. (fallot* adj2 trilogy).tw.
53. turner* syndrome.tw.
54. bonnevie‐ullrich syndrome.tw.
55. bonnevie ullrich syndrome.tw.
56. bonnevie‐ullrich status.tw.
57. bonnevie ullrich status.tw.
58. ullrich‐turner syndrome.tw.
59. (gonadal adj2 dysgenesis).tw.
60. univentricular heart.tw.
61. arterial switch.tw.
62. norwood*.tw.
63. or/1‐62
64. levosimendan/
65. levosimendan.tw.
66. levosimedan.tw.
67. or1259.tw.
68. "or 1259".tw.
69. simdax.tw.
70. cardiotonic agent/
71. (inotropic adj2 (agent* or drug* or medicat* or act*)).tw.
72. inodilator*.tw.
73. (calcium adj2 sensiti*).tw.
74. or/64‐73
75. 63 and 74
76. random$.tw.
77. factorial$.tw.
78. crossover$.tw.
79. cross over$.tw.
80. cross‐over$.tw.
81. placebo$.tw.
82. (doubl$ adj blind$).tw.
83. (singl$ adj blind$).tw.
84. assign$.tw.
85. allocat$.tw.
86. volunteer$.tw.
87. crossover procedure/
88. double blind procedure/
89. randomized controlled trial/
90. single blind procedure/
91. 76 or 77 or 78 or 79 or 80 or 81 or 82 or 83 or 84 or 85 or 86 or 87 or 88 or 89 or 90
92. (animal/ or nonhuman/) not human/
93. 91 not 92
94. 75 and 93

Web of Science

# 15 #14 AND #13
# 14 TS=(random* or blind* or allocat* or assign* or trial* or placebo* or crossover* or cross‐over*)
# 13 #12 AND #9
# 12 #11 OR #10
# 11 TS=("inotropic agent*" or "inotropic drug*" or "inotropic medicat*" or "inotropic act*" or inodilator* or "calcium sensiti*")
# 10 TS=(levosimendan or levosimedan or or1259 or "or 1259" or simdax)
# 9 #8 OR #7 OR #6 OR #5 OR #4 OR #3 OR #2 OR #1
# 8 TS=("turner* syndrome" or "bonnevie‐ullrich syndrome" or "bonnevie ullrich syndrome" or "bonnevie‐ullrich status" or "bonnevie ullrich status" or "ullrich‐turner syndrome" or "gonadal dysgenesis" or "univentricular heart" or "arterial switch" or norwood*)
# 7 TS=("leopard syndrome*" or "cardiomyopathic* lentiginosis" or "lentigines syndrome*" or levocardia or "marfan* syndrome" or "noonan syndrome" or "turner* syndrome" or "fallot* tetralogy" or "transpos* arter*" or "transpos* vessel*" or "tricuspid atresias" or "fallot* trilogy")
# 6 TS=("heart septal defect*" or "cardiac septal defect*" or "heterotaxy syndrome*" or "polysplenia syndrome*" or "asplenia syndrome*" or "ambiguus situs" or isomerism or "ivemark syndrome" or "visceral heterotax*" or "hypoplastic left heart syndrome" or "isolated noncompaction" or "isolated non‐compaction")
# 5 TS=(dextrocardia* or "kartagener* syndrome*" or "kartagener* triad" or "siewert syndrome*" or "polynesian bronchiectas?s" or "primary ciliary dyskinesia" or "paten* ductus arteriosus" or "ebstein* anomal*" or "ebstein* malform*" or "ectopia cordis" or "Eisenmenger* complex" or "Eisenmenger* syndrome")
# 4 TS=("hepatic ductular hypoplasia*" or "aort* coarctation*" or "arrhythmogenic ventricular" or "Barth Syndrome" or "heart* triatria*" or "cor triatria*" or "subdivided atrium*" or "coronary vessel anomal*" or "myocardial bridging*" or "criss‐cross heart*" or "crisscross heart*" or "criss cross heart*")
# 3 TS=("deletion syndrome*" or "alagille* syndrome*" or "watson* syndrome*" or hepatofacioneurocardiovertebral or "cardiovertebral syndrome*" or "arteriohepatic dysplasia*" or "hepatic ductular hypoplasia*" or "cardiovertebral syndrome" or "arteriohepatic dysplasia*")
# 2 TS=(congenital heart or congenital cardiac or congenital cardio*)
# 1 TS=(heart defect* or heart abnormal* or heart malform*)

Study flow diagram.
Figures and Tables -
Figure 1

Study flow diagram.

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Figures and Tables -
Figure 2

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Figures and Tables -
Figure 3

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Forest plot of comparison: 1 Mortality, outcome: 1.1 Mortality.
Figures and Tables -
Figure 4

Forest plot of comparison: 1 Mortality, outcome: 1.1 Mortality.

Forest plot of comparison: 2 Low cardiac output syndrome (LCOS), outcome: 2.1 LCOS.
Figures and Tables -
Figure 5

Forest plot of comparison: 2 Low cardiac output syndrome (LCOS), outcome: 2.1 LCOS.

Comparison 1 Mortality, Outcome 1 Mortality.
Figures and Tables -
Analysis 1.1

Comparison 1 Mortality, Outcome 1 Mortality.

Comparison 2 Low cardiac output syndrome (LCOS), Outcome 1 LCOS.
Figures and Tables -
Analysis 2.1

Comparison 2 Low cardiac output syndrome (LCOS), Outcome 1 LCOS.

Comparison 3 Length of ICU stay, Outcome 1 Length of ICU stay (days).
Figures and Tables -
Analysis 3.1

Comparison 3 Length of ICU stay, Outcome 1 Length of ICU stay (days).

Comparison 3 Length of ICU stay, Outcome 2 Length of ICU stay (days).
Figures and Tables -
Analysis 3.2

Comparison 3 Length of ICU stay, Outcome 2 Length of ICU stay (days).

Comparison 4 Length of hospital stay, Outcome 1 Length of hospital stay (days).
Figures and Tables -
Analysis 4.1

Comparison 4 Length of hospital stay, Outcome 1 Length of hospital stay (days).

Comparison 5 Duration of mechanical ventilation, Outcome 1 Duration of mechanical ventilation (days).
Figures and Tables -
Analysis 5.1

Comparison 5 Duration of mechanical ventilation, Outcome 1 Duration of mechanical ventilation (days).

Comparison 5 Duration of mechanical ventilation, Outcome 2 Duration of mechanical ventilation (days).
Figures and Tables -
Analysis 5.2

Comparison 5 Duration of mechanical ventilation, Outcome 2 Duration of mechanical ventilation (days).

Comparison 6 Mechanical circulatory support or cardiac transplantation, Outcome 1 Mechanical circulatory support or cardiac transplantation.
Figures and Tables -
Analysis 6.1

Comparison 6 Mechanical circulatory support or cardiac transplantation, Outcome 1 Mechanical circulatory support or cardiac transplantation.

Summary of findings for the main comparison. Prophylactic levosimendan compared to standard treatment in children having undergone heart surgery

Prophylactic levosimendan compared to standard treatment in children following heart surgery

Patient or population: paediatric patients following heart surgery
Setting: institutions providing postoperative care after heart surgery for congenital heart disease
Intervention: levosimendan
Comparison: standard inotropes

Outcomes

Anticipated absolute effects* (95% CI)

Relative effect
(95% CI)

№ of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Risk with standard inotropes

Risk with levosimendan

Mortality
follow‐up: range 1 day to 6 days

Study population

RR 0.47
(0.12 to 1.82)

123
(3 RCTs)

⊕⊕⊝⊝
LOW 1, 2

57 per 1000

27 per 1000
(7 to 104)

Low cardiac output syndrome (LCOS)
follow‐up: range 1 day to 6 days

Study population

RR 0.64
(0.39 to 1.04)

83
(2 RCTs)

⊕⊕⊝⊝
LOW 1, 3

367 per 1000

235 per 1000
(143 to 381)

Length of intensive care unit stay (Length of ICU stay)
follow‐up: range 1 day to 6 days

The mean length of stay in the ICU in the control groups ranged from 2.05 to 11 days

The mean length of stay in ICU in the intervention groups was 0.33 days higher (1.16 lower to 1.82 higher)

188
(4 RCTs)

⊕⊕⊝⊝
LOW 1, 4

Length of hospital stay
follow‐up: range 1 day to 6 days

The mean length of hospital stay in the control groups ranged from 15 to 15.8 days

The mean length of hospital stay in the intervention groups was 0.26 days higher
(3.50 lower to 4.03 higher)

75
(2 RCTs)

⊕⊕⊝⊝
LOW 1, 2

Duration of mechanical ventilation
follow‐up: range 1 day to 6 days

The mean duration of mechanical ventilation in the control groups ranged from 0.29 to 6.5 days

The mean duration of mechanical ventilation in the intervention groups was 0.04 days lower
(0.08 lower to 0.00 higher)

208
(5 RCTs)

⊕⊕⊝⊝
LOW 1, 4

Mechanical circulatory support or cardiac transplantation
follow‐up: range 1 day to 6 days

Study population

RR 1.49
(0.19 to 11.37)

60
(2 RCTs)

⊕⊕⊝⊝
LOW 1, 2

10 per 1000

14 per 1000
(2 to 108)

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

CI: Confidence interval; RR: Risk ratio; OR: Odds ratio; MD: mean difference.

GRADE Working Group grades of evidence
High quality: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 Downgraded for imprecision due to small sample size.

2 Downgraded for imprecision due to few number of events (less than 300).

3 Detection of outcome potentially dependent on study personnel: risk of detection bias in two studies due to unblinded setting.

4 Considerable inconsistency between study results.

Figures and Tables -
Summary of findings for the main comparison. Prophylactic levosimendan compared to standard treatment in children having undergone heart surgery
Comparison 1. Mortality

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Mortality Show forest plot

3

123

Risk Ratio (M‐H, Random, 95% CI)

0.47 [0.12, 1.82]

Figures and Tables -
Comparison 1. Mortality
Comparison 2. Low cardiac output syndrome (LCOS)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 LCOS Show forest plot

2

83

Risk Ratio (M‐H, Random, 95% CI)

0.64 [0.39, 1.04]

Figures and Tables -
Comparison 2. Low cardiac output syndrome (LCOS)
Comparison 3. Length of ICU stay

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Length of ICU stay (days) Show forest plot

4

188

Mean Difference (IV, Random, 95% CI)

0.33 [‐1.16, 1.82]

2 Length of ICU stay (days) Show forest plot

4

188

Std. Mean Difference (IV, Random, 95% CI)

‐0.05 [‐0.54, 0.44]

Figures and Tables -
Comparison 3. Length of ICU stay
Comparison 4. Length of hospital stay

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Length of hospital stay (days) Show forest plot

2

75

Mean Difference (IV, Random, 95% CI)

0.26 [‐3.50, 4.03]

Figures and Tables -
Comparison 4. Length of hospital stay
Comparison 5. Duration of mechanical ventilation

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Duration of mechanical ventilation (days) Show forest plot

5

208

Mean Difference (IV, Random, 95% CI)

‐0.04 [‐0.08, 0.00]

2 Duration of mechanical ventilation (days) Show forest plot

5

208

Std. Mean Difference (IV, Random, 95% CI)

‐0.08 [‐0.43, 0.27]

Figures and Tables -
Comparison 5. Duration of mechanical ventilation
Comparison 6. Mechanical circulatory support or cardiac transplantation

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Mechanical circulatory support or cardiac transplantation Show forest plot

2

60

Risk Ratio (M‐H, Random, 95% CI)

1.49 [0.19, 11.37]

Figures and Tables -
Comparison 6. Mechanical circulatory support or cardiac transplantation